These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1234594)

  • 41. Bioavailability and half-life of two preparations of flucloxacillin.
    Paton DM; Mander P; Avery RJ
    N Z Med J; 1982 Nov; 95(719):766-8. PubMed ID: 6959033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The binding of isoxazolyl penicillins to human serum proteins.
    Ulmann U
    Arzneimittelforschung; 1977; 27(11):2136-8. PubMed ID: 580016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flucloxacillin-associated liver damage.
    Lobatto S; Dijkmans BA; Mattie H; Van Hooff JP
    Neth J Med; 1982; 25(2):47-8. PubMed ID: 7070561
    [No Abstract]   [Full Text] [Related]  

  • 44. In vivo antibacterial activity of dipeptides of penicillins.
    Beskid G; Grunberg E
    Med Exp Int J Exp Med; 1968; 18(4):327-30. PubMed ID: 5757159
    [No Abstract]   [Full Text] [Related]  

  • 45. [On contemporary rational penicillin treatment].
    Welcker ER
    Z Arztl Fortbild (Jena); 1965 Dec; 59(23):1250-3. PubMed ID: 5178687
    [No Abstract]   [Full Text] [Related]  

  • 46. The Rm values of newer penicillins for investigating their spectrum of antibacterial activity.
    Biagi GL; Guerra MC; Barbaro AM; Cantelli-Forti G; Rossi T
    Boll Soc Ital Biol Sper; 1975 Apr; 51(7):403-5. PubMed ID: 1044282
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of bone levels after intramuscular administration of cephradine ('Velosef') or flucloxacillin/ampicillin in hip replacement.
    Brooks S; Dent AR
    Pharmatherapeutica; 1984; 3(10):642-9. PubMed ID: 6463064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Penicillinase resistant semisynthetic penicillins--antibacterial action and circulatory characteristics of patients' blood].
    Fomina IP; Kuznetsova SM; Vasil'ev VK; Bodunkova LE
    Antibiotiki; 1971 Feb; 16(2):153-8. PubMed ID: 5208228
    [No Abstract]   [Full Text] [Related]  

  • 49. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
    Kondo M; Oishi T; Tsuchiya K
    J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of combination amoxicillin, flucloxacillin 1:1 in bacterial infections of the lower respiratory tract].
    Rimoldi R; Brunetta F; Chiaravalli E
    G Ital Chemioter; 1978; 25(1):5-12. PubMed ID: 751850
    [No Abstract]   [Full Text] [Related]  

  • 51. [Synergistic activity of cloxacillin (Syntarpen 201) with other beta-lactam antibiotics against Gram-negative enteric bacteria].
    Bobrowski M; Gebicka K
    Pol Tyg Lek; 1971 May; 26(20):764-6. PubMed ID: 5580934
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of dicloxacillin, oxacillin, and nafcillin upon staphylococcal population and rate of healing of soft-tissue lesions.
    Hartman RE; Carleton J; Lustberg A; Hamburger M
    Antimicrob Agents Chemother (Bethesda); 1966; 6():64-8. PubMed ID: 5985303
    [No Abstract]   [Full Text] [Related]  

  • 53. The metabolic disposition of flucloxacillin in patients with impaired kidney function.
    Thijssen HH; Wolters J
    Eur J Clin Pharmacol; 1982; 22(5):429-34. PubMed ID: 7117355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electroencephalographic effects of flucloxacillin in rats.
    Contreras S; Kramer MV; Pesce ME
    Pharmacol Toxicol; 1993; 72(4-5):205-7. PubMed ID: 8372038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Molecular-biological bases of the mechanism of action of penicillins and cephasporins].
    Bär H; Zarnack J
    Pharmazie; 1970 Jan; 25(1):10-22. PubMed ID: 4987180
    [No Abstract]   [Full Text] [Related]  

  • 56. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    Calain P; Krause KH; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
    J Infect Dis; 1987 Feb; 155(2):187-91. PubMed ID: 2949024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical evaluation of the effects of flucloxacillin in skin and soft tissue infections in the Ivory Coast].
    Amery KV
    Pharmatherapeutica; 1988; 5(3):193-7. PubMed ID: 2834747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does Staphylococcus aureus acquire resistance to methicillin during beta-lactam therapy?
    Morris AJ; Lang SD
    N Z Med J; 1987 Aug; 100(829):504. PubMed ID: 3455524
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical efficacy of benzathine cloxacillin in dry-cow mastitis treatment.
    Hill GN; Keefe TJ
    Mod Vet Pract; 1974 Nov; 55(11):843-4, 846. PubMed ID: 4437515
    [No Abstract]   [Full Text] [Related]  

  • 60. Toxicities of flucloxacillin and dicloxacillin--is there really a difference?
    Gosbell IB; Turnidge JD; Tapsall JW; Benn RA
    Med J Aust; 2000 Nov; 173(9):500-1. PubMed ID: 11149309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.